Manufacturer record
Zest Pharma: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
7 batches manufactured by Zest Pharma (Madhya Pradesh) were declared Not of Standard Quality between December 2019 and November 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
7 records linked to Zest Pharma in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Doxycycline Hydrochloride Capsule IP 100 mg | C5009Mfg 2025-07 · Exp 2027-06 | Dissolution (Doxycycline)Dissolution | Food & Drugs Laboratory, VadodaraState lab | Nov 2025 |
| Doxycycline Hydrochloride Capsule IP 100 mg | C5007Mfg 2025-07 · Exp 2027-06 | Dissolution (Doxycycline)Dissolution | Food & Drugs Laboratory, VadodaraState lab | Nov 2025 |
| CEFADROXIL TABLETS I.P. 500 mg | T2072Mfg 2022-03 · Exp 2024-02 | DissolutionDissolution | RDTL GuwahatiState lab | Aug 2022 |
| CEFIXIME DISPERSIBLE TABLETS IP 200 MG | T0037Mfg 2020-01 · Exp 2021-12 | Disintegration Test and Uniformity of DispersionDisintegration | RDTL ChandigarhCDSCO lab | Sep 2021 |
| Norfloxacin Tablet I.P. 400mg | T-9457Mfg 2019-10 · Exp 2021-09 | DissolutionDissolution | CDTL MumbaiCDSCO lab | Apr 2020 |
| Vitamin B-complex Tablet (Prophylactic) NFI (III) | T8605Mfg 2018-12 · Exp 2020-05 | Assay of Vitamin B1Assay | CDTL MumbaiCDSCO lab | Jan 2020 |
| Norfloxacin Tablets IP 400 mg | T8422Mfg 2018-08 · Exp 2020-07 | DissolutionDissolution | CDTL MumbaiCDSCO lab | Dec 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.